Furthermore, HGF levels were higher in patients with ISS stage II/III disease compared with those having ISS stage I MM (Figure 5C-D), suggesting that the magnitude of HGF release reflects disease burden. The gene discussed is HGF; the disease is Miyoshi myopathy.